Nighttime Synchrony of Your Nutrition and Circadian Health
NCT ID: NCT07329283
Last Updated: 2026-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2025-12-19
2031-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. People will complete surveys and medical tests. The study will last about 4 to 6 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Circadian Intervention to Improve Cardiometabolic Health
NCT05943626
Countermeasures to Circadian Misalignment
NCT04966351
Cardiometabolic Risk of Shiftwork
NCT01264913
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
NCT05551325
Biomarkers of Increased Free Living Sleep Time
NCT04214184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sleep Restriction with Central and Peripheral Alignment
(Arm "A")-Control condition with central and peripheral aligned circadian rhythms
No interventions assigned to this group
Sleep Restriction with Central Clock Misalignment
(Arm "B")-Misalignment of the central clock by nighttime electrical light exposure and dim-light in morning hours.
Central Clock Misalignment
Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.
Sleep Restriction with Peripheral Misalignment
(Arm "C")-Misalignment of peripheral oscillators by shifting the majority of food intake to the nighttime hours.
Peripheral Misalignment
Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Central Clock Misalignment
Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.
Peripheral Misalignment
Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body Mass Index (BMI): 18.5-24.9 kg/m2
3. Sleep Habits: habitual self-reported average total sleep time (TST) 7-9 hours per night for prior 6 months
Exclusion Criteria
2. Evidence of significant organ system dysfunction or disease (e.g., heart disease, diabetes)
3. Fasting plasma glucose ≥100 mg/dL
4. Major psychiatric illness (e.g., major depressive disorder)
5. Cancer that has been in remission less than 5 years
6. History of shift-work in prior year
7. Weight change \>5% of body weight over prior six months
8. Currently following a weight-loss program
9. Menopause
10. Pregnant/nursing
11. Greater than 5-day variation in menstrual cycle length month-to-month
12. Currently smoking
13. Alcohol intake \>14 drinks/week or \>3 drinks/day.
14. Use of prescription medications (except oral contraceptives) within one month prior to or during in-lab visits.
15. Consumption of illegal drugs or \>500mg per day of caffeine.
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Depner
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Depner, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Utah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
College of Health Research Complex - University of Utah, Salt Lake City 84112
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
185590
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.